Cargando…

The impact of adverse events on health-related quality of life among patients receiving treatment for drug-resistant tuberculosis in Johannesburg, South Africa

BACKGROUND: Adverse events (AEs) are common during treatment of drug-resistant tuberculosis (DR-TB). Little is known about the health-related quality of life (HRQoL) of patients receiving treatment for DR-TB or the effect of AEs on HRQoL. METHODS: We conducted a cross-sectional study among adult pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sineke, Tembeka, Evans, Denise, Schnippel, Kathryn, van Aswegen, Heleen, Berhanu, Rebecca, Musakwa, Nozipho, Lönnmark, Elisabet, Long, Lawrence, Rosen, Sydney
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545023/ https://www.ncbi.nlm.nih.gov/pubmed/31151398 http://dx.doi.org/10.1186/s12955-019-1155-4

Ejemplares similares

Treatment initiation among persons diagnosed with drug resistant tuberculosis in Johannesburg, South Africa
por: Evans, Denise, et al.
Publicado: (2017)

Impact of Xpert MTB/RIF and decentralized care on linkage to care and drug-resistant tuberculosis treatment outcomes in Johannesburg, South Africa
por: Evans, Denise, et al.
Publicado: (2018)

Early Outcomes Of Decentralized Care for Rifampicin-Resistant Tuberculosis in Johannesburg, South Africa: An Observational Cohort Study
por: Berhanu, Rebecca, et al.
Publicado: (2016)

Perceived efficacy of HIV treatment-as-prevention among university students in Johannesburg, South Africa
por: Bor, Jacob, et al.
Publicado: (2021)

Perceived barriers to the uptake of health services among first-year university students in Johannesburg, South Africa
por: Musakwa, Nozipho Orykah, et al.
Publicado: (2021)

Cost outcome analysis of decentralized care for drug-resistant tuberculosis in Johannesburg, South Africa
por: van Rensburg, Craig, et al.
Publicado: (2019)

Self-reported motivators for HIV testing in the treat-all era among HIV positive patients in Johannesburg, South Africa
por: Mokhele, Idah, et al.
Publicado: (2021)

Understanding the Reasons for Deferring ART Among Patients Diagnosed Under the Same-Day-ART Policy in Johannesburg, South Africa
por: Onoya, Dorina, et al.
Publicado: (2021)

Women’s costs for accessing comprehensive sexual and reproductive health services: findings from an observational study in Johannesburg, South Africa
por: Lince-Deroche, Naomi, et al.
Publicado: (2019)

Impact of the test and treat policy on delays in antiretroviral therapy initiation among adult HIV positive patients from six clinics in Johannesburg, South Africa: results from a prospective cohort study
por: Onoya, Dorina, et al.
Publicado: (2020)

The High Cost of HIV-Positive Inpatient Care at an Urban Hospital in Johannesburg, South Africa
por: Long, Lawrence C., et al.
Publicado: (2016)

Mapping cycling patterns and trends using Strava Metro data in the city of Johannesburg, South Africa
por: Musakwa, Walter, et al.
Publicado: (2016)

Societal context-dependent multi-modal transportation network augmentation in Johannesburg, South Africa
por: Moyo, Thembani, et al.
Publicado: (2021)

Severe adverse events during second-line tuberculosis treatment in the context of high HIV Co-infection in South Africa: a retrospective cohort study
por: Schnippel, Kathryn, et al.
Publicado: (2016)

Predictive and prognostic properties of TB-LAM among HIV-positive patients initiating ART in Johannesburg, South Africa
por: d'Elia, Alexander, et al.
Publicado: (2015)

Delays, interruptions, and losses from prevention of mother-to-child transmission of HIV services during antenatal care in Johannesburg, South Africa: a cohort analysis
por: Schnippel, Kathryn, et al.
Publicado: (2015)

“I was scared dating… who would take me with my status?”—Living with HIV in the era of UTT and U = U: A qualitative study in Johannesburg, South Africa
por: Sineke, Tembeka, et al.
Publicado: (2023)

How to Estimate the Cost of Point-of-Care CD4 Testing in Program Settings: An Example Using the Alere Pima™ Analyzer in South Africa
por: Larson, Bruce, et al.
Publicado: (2012)

The relation between efavirenz versus nevirapine and virologic failure in Johannesburg, South Africa
por: Shearer, Kate, et al.
Publicado: (2014)

Attrition in HIV care following HIV diagnosis: a comparison of the pre‐UTT and UTT eras in South Africa
por: Onoya, Dorina, et al.
Publicado: (2021)

Pneumonic Plague in Johannesburg, South Africa, 1904
por: Evans, Charles M., et al.
Publicado: (2018)

High rates of death and loss to follow-up by 12 months of rifampicin resistant TB treatment in South Africa
por: Hirasen, Kamban, et al.
Publicado: (2018)

HIV Treatment Outcomes Among Patients Initiated on Antiretroviral Therapy Pre and Post-Universal Test and Treat Guidelines in South Africa
por: Hirasen, Kamban, et al.
Publicado: (2020)

Experiences in receiving financial incentives to access HIV care in Johannesburg, South Africa
por: Schlehr, Sara Rachel, et al.
Publicado: (2022)

Scaling up Xpert MTB/RIF technology: the costs of laboratory- vs. clinic-based roll-out in South Africa
por: Schnippel, Kathryn, et al.
Publicado: (2012)

Can Short-Term Use of Electronic Patient Adherence Monitoring Devices Improve Adherence in Patients Failing Second-Line Antiretroviral Therapy? Evidence from a Pilot Study in Johannesburg, South Africa
por: Evans, Denise, et al.
Publicado: (2016)

Early loss to follow up after enrolment in pre-ART care at a large public clinic in Johannesburg, South Africa
por: Larson, Bruce A, et al.
Publicado: (2010)

Low prevalence of depressive symptoms among stable patients on antiretroviral therapy in Johannesburg, South Africa
por: Shearer, Kate, et al.
Publicado: (2018)

Timing of pregnancy, postpartum risk of virologic failure and loss to follow-up among HIV-positive women
por: Onoya, Dorina, et al.
Publicado: (2017)

Predictors of switch to and early outcomes on third-line antiretroviral therapy at a large public-sector clinic in Johannesburg, South Africa
por: Evans, Denise, et al.
Publicado: (2018)

The Impact and Cost of Scaling up GeneXpert MTB/RIF in South Africa
por: Meyer-Rath, Gesine, et al.
Publicado: (2012)

Cost of using a patient tracer to reduce loss to follow-up and ascertain patient status in a large antiretroviral therapy program in Johannesburg, South Africa
por: Rosen, Sydney, et al.
Publicado: (2010)

Same-Day CD4 Testing to Improve Uptake of HIV Care and Treatment in South Africa: Point-of-Care Is Not Enough
por: Larson, Bruce A., et al.
Publicado: (2013)

Treatment outcomes of over 1000 patients on second‐line, protease inhibitor‐based antiretroviral therapy from four public‐sector HIV treatment facilities across Johannesburg, South Africa
por: Shearer, Kate, et al.
Publicado: (2016)

Environmental Silica Dust Exposure and Pulmonary Tuberculosis in Johannesburg, South Africa
por: Kootbodien, Tahira, et al.
Publicado: (2019)

The Impact of Choice of NNRTI on Short-Term Treatment Outcomes among HIV-Infected Patients Prescribed Tenofovir and Lamivudine in Johannesburg, South Africa
por: Shearer, Kate, et al.
Publicado: (2013)

Health provider perspectives on the implementation of the same-day-ART initiation policy in the Gauteng province of South Africa
por: Onoya, Dorina, et al.
Publicado: (2021)

Treatment outcomes of HIV-positive patients on first-line antiretroviral therapy in private versus public HIV clinics in Johannesburg, South Africa
por: Moyo, Faith, et al.
Publicado: (2016)

The reporting of adverse events in Johannesburg Academic Emergency Departments
por: Zoghby, Matthew Gabriel, et al.
Publicado: (2021)

Psychosexual experiences of men following radiotherapy for prostate cancer in Johannesburg, South Africa
por: Phahlamohlaka, Matheko N., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7itbgorglsbj7cquplfi2sgcng